In prostate cancers, PI4KA is overexpressed in metastasis and several chemokine receptors are shown to interact with EFR3 and TTC7 suggesting this interaction brings PI4KA to the PM upon chemokine signaling and contributing to the prostate cancer cell invasion and metastasis34. This evidence concerns the gene TTC7A and prostate carcinoma.